Jpmorgan Chase & CO Phibro Animal Health Corp Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Phibro Animal Health Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 11,243 shares of PAHC stock, worth $248,133. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,243
Previous 16,570
32.15%
Holding current value
$248,133
Previous $214,000
12.15%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PAHC
# of Institutions
143Shares Held
20.3MCall Options Held
4.9KPut Options Held
400-
Black Rock Inc. New York, NY3.5MShares$77.3 Million0.0% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA2.41MShares$53.1 Million0.52% of portfolio
-
Richard Pzena Pzena Investment Management LLC1.84MShares$40.5 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.36MShares$30.1 Million0.0% of portfolio
-
State Street Corp Boston, MA938KShares$20.7 Million0.0% of portfolio
About PHIBRO ANIMAL HEALTH CORP
- Ticker PAHC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 20,337,600
- Market Cap $449M
- Description
- Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...